These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 29329650)
1. Synthesis and anti-hepatocellular carcinoma activity of novel O Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650 [TBL] [Abstract][Full Text] [Related]
2. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability. Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697 [TBL] [Abstract][Full Text] [Related]
3. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents. Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516 [TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety. Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909 [TBL] [Abstract][Full Text] [Related]
6. NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway. Liu L; Fu J; Li T; Cui R; Ling J; Yu X; Ji H; Zhang Y Eur J Pharmacol; 2012 Sep; 691(1-3):61-8. PubMed ID: 22824464 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid. Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis. Chen L; Zhang Y; Kong X; Peng S; Tian J Bioorg Med Chem Lett; 2007 Jun; 17(11):2979-82. PubMed ID: 17446070 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma. Elshaier YAMM; Shaaban MA; Abd El Hamid MK; Abdelrahman MH; Abou-Salim MA; Elgazwi SM; Halaweish F Bioorg Med Chem; 2017 Jun; 25(12):2956-2970. PubMed ID: 28487127 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. Abou-Salim MA; Shaaban MA; Abd El Hameid MK; Elshaier YAMM; Halaweish F Bioorg Chem; 2019 Apr; 85():515-533. PubMed ID: 30807895 [TBL] [Abstract][Full Text] [Related]
11. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity. Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives. Liu X; Sun L; Liu QH; Chen BQ; Liu YM Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368 [TBL] [Abstract][Full Text] [Related]
13. [Synthesis and anti-tumor activity of oleanolic acid derivatives]. Meng YQ; Nie HH; Wang XC; Li D; Ge CX; Zhao N; Chen H; Cao B Yao Xue Xue Bao; 2011 Oct; 46(10):1215-20. PubMed ID: 22242453 [TBL] [Abstract][Full Text] [Related]
14. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo. Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381 [TBL] [Abstract][Full Text] [Related]
15. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell. Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880 [TBL] [Abstract][Full Text] [Related]
16. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs. Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538 [TBL] [Abstract][Full Text] [Related]
17. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis]. Chen L; Shang J; Wang ZF; Zhang YH; Tian JD Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents. Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O Kang F; Ai Y; Zhang Y; Huang Z Eur J Med Chem; 2018 Apr; 149():269-280. PubMed ID: 29501947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]